Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local bupivacaine infiltration after transperineal prostate biopsy
ACTRN12616001310459Phase 3Recruiting
- Sponsor
- Professor Damien Bolton
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of bupivacaine in pain, sponsored by Professor Damien Bolton. Primary endpoints: Postoperative pain assessed by Visual Analogue Scale and Postoperative pain assessed by Short McGill Pain Questionnaire. Started Sep 2016; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on ACTRN12616001310459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001310459.